Abera Bioscience AB (NGM:ABERA)
Sweden · Delayed Price · Currency is SEK 6.50
+0.50 (8.33%)
At close: Jan 30, 2026
Abera Bioscience AB Market Cap
Abera Bioscience AB has a market cap or net worth of 120.16 million as of February 5, 2026. Its market cap has increased by 81.60% in one year.
Market Cap
120.16M
Enterprise Value
96.99M
Revenue
17.30M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.50
Market Cap Chart
Since February 24, 2021, Abera Bioscience AB's market cap has increased from 115.59M to 120.16M, an increase of 3.96%. That is a compound annual growth rate of 0.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 4, 2026 | 123.89M | -1.24% |
| Dec 30, 2025 | 125.44M | 81.17% |
| Dec 30, 2024 | 69.24M | -7.23% |
| Dec 29, 2023 | 74.63M | 20.46% |
| Dec 30, 2022 | 61.96M | -64.21% |
| Dec 30, 2021 | 173.12M | 49.77% |
| Feb 24, 2021 | 115.59M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aquaticus Real Estate AB | 172.48M |
| Valuno Group AB | 160.72M |
| Nowonomics AB | 152.31M |
| Fable Media Group AB | 151.51M |
| Solution International Nordics AB | 147.05M |
| EmbeddedArt Group AB | 146.85M |
| Eurobattery Minerals AB | 138.93M |
| Amido AB | 128.18M |